447
Participants
Start Date
July 31, 2010
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
doxorubicin in combination with palifosfamide-tris
"palifosfamide-tris: 150 mg/m2 3 days every 21 days for a maximum of 6 cycles.~doxorubicin: 75 mg/m2 1 day every 21 days for a maximum of 6 cycles."
doxorubicin in combination with placebo
"doxorubicin: 75 mg/m2 of doxorubicin 1 day every 21 days for a maximum of 6 cycles.~placebo: 250 mL of normal saline 3 days every 21 days for a maximum of 6 cycles."
Princess Alexandra Hospital, Woolloongabba
Cancer Therapy and Research Center, San Antonio
Mount Sinai School of Medicine, New York
University of Pittsburgh, Pittsburgh
Bellin Cancer Center, Green Bay
St.Louis University, St Louis
University of Arkansas for Medical Sciences, Little Rock
Kootenai Cancer Center, Post Falls
Arizona Cancer Center, Tucson
Birmingham
Arizona Oncology Associates, Phoenix
Scottsdale
University of California, Los Angeles, Los Angeles
Los Angeles
University of California, Irvine, Orange
Pomona
Sarcoma Oncology Center, Santa Monica
University of Colorado Cancer Center, Aurora
Rocky Mountain Cancer Centers, Denver
Medical Oncology Hematology Consultants, Newark
MedStar Research Institute, Washington D.C.
Washington D.C.
Jacksonville
Orlando
Moffitt Cancer Center, Tampa
Palm Beach Cancer Institute, West Palm Beach
Emory, Atlanta
Medical College of Georgia, Augusta
Chicago
Park Ridge
Indiana University Simon Cancer Center, Indiannapolis
University of Iowa Hospital and Clinics, Iowa City
Kansas City Cancer Center, Overland Park
New Orleans
LSU Health Sciences Center, Feist-Weiller Cancer Center, Shreveport
Baltimore
Dana-Farber Cancer Institute, Boston
Ann Arbor
Mayo Clinic, Rochester
Washington University School of Medicine, St Louis
Las Vegas
Hackensack
Morristown
Saint Barnabas, West Orange
Albuquerque
Columbia University Medical Center, New York
University of Rochester, Rochester
The Bronx
University of North Carolina, Chapel Hill
Durham
Raleigh
Wake Forest University Health Sciences, Winston-Salem
Summa Health System, Akron
UC Cancer Institute, Cinncinnati
Cleveland Clinic, Cleveland
The Ohio State University Medical Center, Columbus
Cancer Care Associates, Tulsa
Oregon Health and Science University, Portland
Bethelehem
Fox Chase Cancer Center, Philadelphia
Pennsylvania Oncology/Hematology Associates, Philadelphia
Providence
Charleston
Cancer Centers of the Carolinas, Greenville
Memphis
Nashville
Texas Oncology, Bedford
Texas Oncology - Medical City Dallas, Dallas
Utah Cancer Specialists, Salt Lake City
Burlington
Virginia Cancer Specialists, Fairfax
University of Washington/Seattle Cancer Care Alliance, Seattle
University of Wisconsin, Madison
Milwaukee
Ciudad de Buenos Aires
Córdoba
Ramos Mejía
Instituto CAICI, Rosario
Sante Fe
Royal Adelaide Hospital, Adelaide
Camperdown
East Melbourne
The Canberra Hospital, Garran
Garran
Kurralta Park
Nedlands
Antwerp
Brussels
Leuven
Liège
Institution name: Hospital de Câncer de Barretos - Fundação PIOXII, Barretos
Belo Horizonte
Santa Casa da Misericórdia de Curitiba, Curitiba
Florianópolis
Jaú
Hospital da Cidade de Passo Fundo, Passo Fundo
Hospital das Clínicas de Porto Alegre, Porto Alegre
Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre
Centro de Oncologia da Bahia, Salvador
São Paulo
Calgary
Cross Cancer Institute, Edmonton
Mount Sinai Hospital, Toronto
Jewish General Hospital, Montreal
McGill University, Montreal
Santiago
Instituto Clínico Oncológico del Sur, Temuco
Viña del Mar
Bogotá
Medellín
Montería
Angers
Bordeaux
Institut Paoli Calmettes, Marseille
Marseille
Montpellier
Nice
Paris
Toulouse
Villejuif
HELIOS Klinikum Berlin Buch, Bad Sarrow
Universitätsklinikum Köln, Cologne
Hanover
Mannheim
Tuebingen University Hospital, Tübingen
Guatemala City
Jaipur
Mumbai
Nashik
Pune
Secunderabad
Haifa
Shaare Zedek Medical Center, Jerusalem
Jerusalem
Petah Tikva
Ramat Gan
Tel Aviv
Candiolo
Humanitas Cancer Center, Rozzana
Ospedale Gradenigo Oncology, Torino
Centro Hemato Oncologico Paitilla, Panama City
Medical and Research Center, Panama City
Wojewodzkie Centrum Onkologii, Gdansk
Gilwice
Centrum Onkologii Instytut, Warsaw
Bucharest
Cluj-Napoca
Craiova
Moscow
Obninsk
Saint Petersburg
Yaroslavl
Singapore
Badalona
Madrid
Hospital Universitario Puerta de Hierro, Majadahonda
Valencia
Christie Hospital NHS Foundation Trust, Manchester
North Adelaide Oncology, Adelaide
Prince of Wales Hospital, Randwick
The Royal Marsden NHS Foundation Trust Sarcoma, London
Lead Sponsor
Alaunos Therapeutics
INDUSTRY